Auspex Pharmaceuticals' Series B - II Round

Auspex Pharmaceuticals raised a round of funding on August 05, 2009.

Auspex Pharmaceuticals is a privately held biopharmaceutical company focused on the use of deuterium in medicinal chemistry, and the treatment of hyperkinetic movement disorders including Huntington's…

Articles about Auspex Pharmaceuticals' Series B - II Round: